Filtering by
- All Subjects: Cancer
Ankle monitors are not the bright, kind alternative to incarceration that they are made to be. Advocates propose them as a solution to overcrowded carceral sites and excessive federal expenditure on public corrections agencies. Their logic being we can release certain incarcerated people to reduce prison, jail, and detention center populations and require them to pay for their monitoring to reduce prison expenditures. While there is potential for ankle monitors to achieve these aspirations, it is necessary to recognize how and where they can produce harm. Rather than being an alternative to incarceration, ankle monitors are a method of incarceration. They serve the same functions and hold the same power as prisons and jails with a more elusive form. In the current implementation of ankle monitors, we see individual bodies being transformed into sources of data to be capitalized upon by the government and private companies. Along with this, there is a shift of the financial burden of incarceration from prisons to the person being punished. This acts to further perpetuate the cycles of poverty and financial oppression that are seen within traditional forms of incarceration. Ankle monitor advocates also claim ankle monitors allow incarcerated people to enjoy freedom beyond prison walls and reintegrate into society. In reality, this is an oversimplification of freedom. Individuals with ankle monitors find themselves to be limited in their freedoms by restricted movement and stigmatization. They are unable to live a “normal” life because their ankle monitors prevent them from doing so. These people cannot move as they please, they cannot find and hold employment, and they cannot interact with people like they normally would. Ankle monitor usage must be critically examined and altered if it is to be considered a meaningful, gentle alternative to incarceration.
The purpose of this project is to analyze the current state of cancer nanomedicine and its challenges. Cancer is the second most deadly illness in the United States after heart disease. Nanomedicine, the use of materials between 1 and 100 nm to for the purpose of addressing healthcare-related problems, is particularly suited for treating it since nanoparticles have properties such as high surface area-to-volume ratios and favorable drug release profiles that make them more suitable for tasks such as consistent drug delivery to tumor tissue. The questions posed are: What are the current nanomedical treatments for cancer? What are the technical, social, and legal challenges related to nanomedical treatments and how can they be overcome? To answer the questions mentioned above, information from several scientific papers on nanomedical treatments for cancer as well as from social science journals was synthesized. Based on the findings, nanomedicine has a wide range of applications for cancer drug delivery, detection, and immunotherapy. The main technical challenge related to nanomedical treatments is navigating through biological barriers such as the mononuclear phagocyte system, the kidney, the blood-brain barrier, and the tumor microenvironment. Current approaches to meeting this challenge include altering the size, shape, and charge of nanoparticles for easier passage. The main social and legal challenge related to nanomedical treatments is the difficulty of regulating them due to factors such as the near impossibility of detecting nanowaste. Current approaches to meeting this challenge include the use of techniques such as scanning tunneling microscopy and atomic force microscopy to help distinguish nanowaste from the surroundings. More research will have to be done in these and other areas to enhance a major cancer-fighting tool.